Full-Time
Clinical intelligence platform for healthcare quality
$170k - $190k/yr
Senior
New York, NY, USA
Preference for candidates located in the Eastern or Central Time Zones. Local employees come into the office on Wednesdays for collaboration.
Covera Health focuses on enhancing the quality of healthcare, particularly in the field of radiology, through its clinical intelligence platform. This platform uses scientifically validated tools to help doctors make more accurate diagnoses, which ultimately improves patient care. Covera Health works with major employers, payers, and healthcare organizations, such as Walmart and Microsoft, to provide insights and tools powered by artificial intelligence. Their business model is based on partnerships with these organizations to implement programs that promote effective care and quality improvement on a large scale. Covera Health primarily serves insured Americans and aims to raise healthcare standards across the country.
Company Size
51-200
Company Stage
Series C
Total Funding
$86M
Headquarters
New York City, New York
Founded
2017
Help us improve and share your feedback! Did you find this helpful?
Health Insurance
Dental Insurance
Vision Insurance
Stock Options
401(k) Retirement Plan
Unlimited Paid Time Off
Commuter Benefits
Covera Health launches AI platform to detect hidden health risks in women.
Covera Health just launched its new artificial intelligence-enabled platform designed specifically to detect early signs of several diagnoses exclusive to women.
Covera Health launches AI platform for women's imaging.
Methodology for calculating the financial impact was reviewed by premier actuarial firm, Milliman, Inc.NEW YORK, May 28, 2024 /PRNewswire/ -- Covera Health , the leading AI-enabled technology company focused on radiology performance measurement and patient impact, today announced findings from its analysis of downstream healthcare spend for patients receiving care at Covera-designated, high-quality imaging facilities. Covera estimated a reduction of up to $2,487 (or 12%) in combined 12-month medical and pharmacy claims cost for patients undergoing high-tech imaging. The study comparison covered a span of three years, was run against a matched control group undergoing imaging at non-Covera-designated facilities, and relied on historical medical and pharmacy claims data from Covera's existing patient population across most of the United States.Covera's unique designation process is designed to reduce the frequency and severity of misdiagnoses that patients experience during the diagnostic stage of care, ultimately improving overall health outcomes, reducing unnecessary healthcare costs, and avoiding complications in downstream care. Covera's analysis demonstrated that patients undergoing high-tech imaging (CT, MRI) at Covera-designated facilities averaged between 6% - 12% lower downstream costs (i.e. imaging and post-imaging costs) compared to the matched control group, largely driven by fewer hospital admissions, ED visits and outpatient services."The notion that radiology is just another commodity in healthcare is outdated and risky," said Ron Vianu, Co-Founder and CEO of Covera Health. "At Covera, we're not just challenging this view; we're dismantling it by demonstrating that high-quality radiology care is a critical determinant of patient outcomes and a key driver in reducing downstream healthcare costs."The methodology for estimating the financial impact of Covera's program was reviewed by Milliman, Inc ., a premier global consulting and actuarial firm
Through the acquisition, CoRead's services will be integrated into Covera's platform.